David Alvarez Cespedes
Dermatology · Boston, MANPI 1346816568
Payments from drug & device makers
Across 104 payments — averaging $56.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$913
- Johnson & Johnson$857
- E.r. Squibb & Sons, L.L.C.$805
- Janssen Scientific Affairs, LLC$653
- Sanofi$431
- Dermavant Sciences, Inc.$424
- plus $2K from 15 others
What the payments were for
- Travel & lodging$2815%
- Food & beverage$5,20789%
- Education$3426%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $913 |
| Johnson & Johnson | 26 | $857 |
| E.r. Squibb & Sons, L.L.C. | 8 | $805 |
| Janssen Scientific Affairs, LLC | 7 | $653 |
| Sanofi | 9 | $431 |
| Dermavant Sciences, Inc. | 4 | $424 |
| Novartis | 14 | $337 |
| Lilly USA, LLC | 3 | $221 |
| Arcutis Biotherapeutics, Inc. | 3 | $216 |
| UCB, Inc. | 3 | $172 |
| Boehringer Ingelheim | 2 | $141 |
| Almirall LLC | 1 | $137 |
| Sun Pharmaceutical Industries Inc. | 1 | $129 |
| LEO Pharma Inc. | 1 | $108 |
| Verrica Pharmaceuticals Inc. | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Galderma Laboratories, L.p. | 2 | $45 |
| Incyte Corporation | 1 | $31 |
| Pfizer | 1 | $27 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Resmed Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,830 in reported general payments places this provider in the 75th percentile of 552 dermatology providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $58,654 |
| Tacrolimus | 21 | $4,184 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boston
- Alexandra KimballBoston$3.7M
- Gideon SmithBoston$2.6M
- Tarannum JaleelBoston$1.3M
- Maria Beatrice AloraBoston$1.3M
- Martina PorterBoston$1.1M
- Arash MostaghimiBoston$1M
- Emmy GraberBoston$882K
- Ruth Ann VleugelsBoston$786K
- Maryanne SennaBoston$783K
- Gabriela CobosBoston$558K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.